Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Board Evaluation Review of Medicines and Healthcare products Regulatory Agency

Medicines and Healthcare Products Regulatory Agency

This public procurement record has 1 release in its history.

Award

04 Sep 2026 at 15:30

UK7 - Contract Details Notice
Summary of the contracting process

The Medicines and Healthcare products Regulatory Agency (MHRA) commissioned an external review of the effectiveness of its board. This is a business and management consultancy service, focused on assessing how well the agency’s board operates and performs. The work is for MHRA, a central government public authority based at 10 South Colonnade, Canary Wharf, London. The requirement is specific to governance and board evaluation within a medicines and healthcare regulator, rather than general operational, clinical or pharmaceutical services. A suitable provider would therefore need to understand board effectiveness, public-sector governance and the operating context of a national regulatory organisation. The awarded supplier, Praesta Partners LLP, is recorded as a small or medium-sized enterprise.

The procurement is complete and has been awarded under a below-threshold direct procedure without competition. Praesta Partners LLP was selected for the board evaluation review. The contract was signed on 31 August 2026 and runs from 1 September 2026 to 31 December 2026. Its value is £35,000 excluding VAT and £42,000 including VAT. The contract is active, and the award is active. The procurement used a single lot, which is complete. The service was classified as business and management consultancy and related services. The available outcome information records the selected supplier and contract terms; the procurement was not conducted through an open or competitive tender process.

For consultancy firms specialising in board evaluation, governance review and organisational effectiveness, this award demonstrates demand from a central government regulator for a focused external assessment of board performance. Competitors seeking similar work would need to show credible experience evaluating boards, reviewing governance effectiveness and producing independent findings for senior public-sector stakeholders. Understanding how a regulatory agency operates would be particularly relevant, including the need to assess oversight, challenge, decision-making and accountability in a medicines and healthcare environment. The successful provider is an SME, indicating that this type of specialist advisory assignment can be delivered by a focused consultancy rather than only a large professional-services firm. Firms with comparable governance and public-sector regulatory experience would be best placed for future requirements from this buyer.

How relevant is this notice?

Notice Information

Notice Title

Board Evaluation Review of Medicines and Healthcare products Regulatory Agency

Notice Description

External review of the effectiveness of Medicines and Healthcare products Regulatory Agency's board.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06f28b
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/084010-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Direct
Procurement Method Details
Below threshold - without competition
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79400000 - Business and management consultancy and related services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£35,000 Under £100K

Notice Dates

Publication Date
4 Sep 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
1 Sep 2026 - 31 Dec 2026 1-6 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Medicines and Healthcare Products Regulatory Agency
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Postcode Area
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Supplier Information

Number of Suppliers
1
Supplier Name

Praesta Partners LLP

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...